Rifaximin in Patients With Diabetic Gastroparesis

NCT04254549 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped Sponsor discontinued placebo. Unable to meet enrollment goals.

Conditions

Crohn Disease
Diabetic Gastroparesis

Interventions

DRUG: Rifaximin
DRUG: Placebo

Sponsor

Mayo Clinic